Clinical

Dr. Eric Segal and Dr. Jurriaan Peters discuss the recently published EPISTOP trial in tuberous sclerosis complex, including its strengths and weaknesses, its implications for clinical practice, and how they approach patient management for this rare epilepsy.

A panel of experts joins Behind the Science to discuss the rising prevalence of diabetes in the US population—one which is also aging toward greater diabetes-driven vision impairment risks including diabetic retinopathy and diabetic macular edema—has physicians wondering why there’s not more collaboration between ophthalmology and diabetes specialists who are often treating the same patients.

With issues surrounding health care cost and coverage being further exacerbated amid the COVID-19 pandemic, a recent survey by Kaiser Family Foundation and the Purchaser Business Group on Health indicates that a majority of executive decision-makers at large employers would support greater government intervention to address these concerns.

Dr. Giulia I. Lane joins Inside the Practice to discuss the recent Urology Practice paper “Patient Reported Shared Decision Making in Urology from the Surgical Consumer Assessment of Healthcare Providers and Systems (CAHPS) Survey,” for which she served as first author.

Mark Painter and Dr. Jonathan Rubenstein join Second Opinion to discuss the Centers for Medicare & Medicaid Services’ recently issued technical corrections to the new evaluation and management guidelines.

Dr. Melissa Stenstrom joins Deep Dive to discuss the importance of skin cancer screenings, as well as encouraging regular sun protection usage among patients. She also talks about the role of telemedicine in skin cancer screenings, her top product recommendations for sun protection and tips on managing patient expectations.

Dr. Jeff Lombardo and Dr. Keith Aqua, both co-investigators of the Validcare study on observing potential liver effects in adults who are using a form of hemp-derived cannabidiol (CBD) for a minimum of 60 days, join Second Opinion to highlight key insights, including what prompted the study, preliminary results, their meeting with the FDA, and what’s next.